Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
Mon, February 6, 2023
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI
Tyler Van Buren Initiated (BBIO) at Buy on, Feb 6th, 2023
Tyler Van Buren of Cowen & Co., Initiated "BridgeBio Pharma, Inc." (BBIO) at Buy on, Feb 6th, 2023.
Tyler has made no other calls on BBIO in the last 4 months.
There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Tyler's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tyler
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $19 on, Friday, November 18th, 2022
